In The News Posted January 31, 2019 Share Posted January 31, 2019 LOS ANGELES, Jan. 31, 2019 /PRNewswire/ -- Trethera Corporation (Trethera), a biopharmaceutical company committed to developing novel drugs targeting cellular nucleotide metabolism for the treatment of cancer, announced the nomination and acceptance of Timothy Donahue to Trethera's Board... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.